Show simple item record

dc.contributor.authorLara-Pezzi, Enrique 
dc.contributor.authorGomez-Salinero, Jesus M. 
dc.contributor.authorGatto, Alberto 
dc.contributor.authorGarcía-Pavía, Pablo
dc.date.accessioned2019-07-26T14:34:22Z
dc.date.available2019-07-26T14:34:22Z
dc.date.issued2013-12
dc.identifier.citationJ Cardiovasc Transl Res. 2013; 6(6):945-55es_ES
dc.identifier.issn1937-5387es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7969
dc.description.abstractAlternative splicing is the main driver of protein diversity and allows the production of different proteins from each gene in the genome. Changes in exon exclusion, intron retention or the use of alternative splice sites can alter protein structure, localisation, regulation and function. In the heart, alternative splicing of sarcomeric genes, ion channels and cell signalling proteins can lead to cardiomyopathies, arrhythmias and other pathologies. Also, a number of inherited conditions and heart-related diseases develop as a result of mutations affecting splicing. Here, we review the impact that changes in alternative splicing have on individual genes and on whole biological processes associated with heart disease. We also discuss promising therapeutic tools based on the manipulation of alternative splicing.es_ES
dc.description.sponsorshipEuropean Union [ITN-289600]; Spanish Ministry of Economy [SAF2012-31451]; Madrid Regional Government [S2010/BMD-2321]; Instituto de Salud Carlos III (Red Enfermedades Cardiovasculares) [RD12/0042/0002]es_ES
dc.language.isoenges_ES
dc.publisherSpringeres_ES
dc.relation.isversionofPostprintes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshAnimals es_ES
dc.subject.meshCalcium Signaling es_ES
dc.subject.meshGene Expression Regulation es_ES
dc.subject.meshGenetic Predisposition to Disease es_ES
dc.subject.meshGenetic Therapy es_ES
dc.subject.meshHeart Diseases es_ES
dc.subject.meshHumans es_ES
dc.subject.meshIntercellular Signaling Peptides and Proteins es_ES
dc.subject.meshIon Channels es_ES
dc.subject.meshMyocardial Contraction es_ES
dc.subject.meshMyocytes, Cardiaces_ES
dc.subject.meshPhenotype es_ES
dc.subject.meshSarcomeres es_ES
dc.subject.meshAlternative Splicing es_ES
dc.titleThe alternative heart: impact of alternative splicing in heart diseasees_ES
dc.typeArtículoes_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID23775418es_ES
dc.format.volume6es_ES
dc.format.number6es_ES
dc.format.page945-55es_ES
dc.identifier.doi10.1007/s12265-013-9482-zes_ES
dc.contributor.funderEuropean Commissiones_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España)es_ES
dc.contributor.funderComunidad de Madrides_ES
dc.contributor.funderInstituto de Salud Carlos III - ISCIIIes_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1937-5395es_ES
dc.relation.publisherversionhttps://doi.org/10.1007/s12265-013-9482-zes_ES
dc.identifier.journalJournal of cardiovascular translational researches_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Regulación Molecular de la Insuficiencia Cardiacaes_ES
dc.repisalud.institucionCNICes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/289600/EUes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2012-31451es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0042/0002es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-CompartirIgual 4.0 Internacional
This item is licensed under a: Atribución-NoComercial-CompartirIgual 4.0 Internacional